Russell Investments Group
PLX icon

Russell Investments Group’s Protalix BioTherapeutics PLX Stock Holding History

Russell Investments Group’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-519
Closed -$607 – 3775
2024
Q2 		$607 Buy
+519
New +$607 ﹤0.01% 3490
2023
Q4 		– Sell
-2,764
Closed -$4.59K – 3286
2023
Q3 		$4.59K Buy
+2,764
New +$4.59K ﹤0.01% 3158